FDA Grants Experimental Coronavirus Drug Benefits For Rare Disease Treatments

Canada News News

FDA Grants Experimental Coronavirus Drug Benefits For Rare Disease Treatments
Canada Latest News,Canada Headlines
  • 📰 NPR
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 63%

The FDA has given remdesivir, an experimental drug for COVID-19, 'orphan drug status.' The decision comes with lucrative incentives to drugmaker Gilead Sciences — including tax breaks and a 7-year monopoly on the drug if it's approved.

Gilead Sciences CEO Daniel O'Day took part in a meeting of the White House Coronavirus Task Force on March 2.Gilead Sciences CEO Daniel O'Day took part in a meeting of the White House Coronavirus Task Force on March 2.The Food and Drug Administration gave an experimental medicine called remdesivir to treat COVID-19 what's called orphan drug status on Monday.

The agency's decision would provide lucrative incentives to the drug's maker, Gilead Sciences, and could keep lower-priced generic versions of the medicine off the market for several years if remdesivir is approved for use, public health advocates say. Clinical trials for remdesivir as a COVID-19 treatment got started in China in early February. Tests of the drug are now enrolling patients elsewhere, including the United States.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NPR /  🏆 96. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA Suspends Routine Food Inspections Amid Coronavirus PandemicFDA Suspends Routine Food Inspections Amid Coronavirus PandemicAbout 77 percent of the U.S. food supply is regulated by the FDA
Read more »

FDA Approves More ‘Rapid’ COVID-19 Coronavirus Tests For Use On FrontlinesFDA Approves More ‘Rapid’ COVID-19 Coronavirus Tests For Use On FrontlinesThe U. S. Food and Drug Administration is approving more rapid molecular diagnostic tests that can be used in temporary screening locations, doctor’s office labs and nursing homes to detect the Coronavirus strain COVID-19 in less than a half hour.
Read more »

FDA will allow doctors to treat critically ill coronavirus patients with blood from survivorsFDA will allow doctors to treat critically ill coronavirus patients with blood from survivorsUnder new emergency protocols approved Tuesday, FDA will allow doctors across the US to begin using plasma donated by coronavirus survivors to treat patients who are critically ill with the virus.
Read more »

FDA Approved Drugs Show Promise Against COVID-19FDA Approved Drugs Show Promise Against COVID-19Two promising new studies suggest that dozens of drugs already approved for use in the United States may prove effective against the new coronavirus.
Read more »

FDA Approves Test That Could Detect Coronavirus In About 45 MinutesFDA Approves Test That Could Detect Coronavirus In About 45 MinutesThe test will begin shipping next week with plans of using the product by the end of the month.
Read more »



Render Time: 2025-03-06 20:36:37